NM_006148.4:c.624C>T
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_006148.4(LASP1):c.624C>T(p.Arg208Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,598,938 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0057 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00062 ( 3 hom. )
Consequence
LASP1
NM_006148.4 synonymous
NM_006148.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.19
Genes affected
LASP1 (HGNC:6513): (LIM and SH3 protein 1) This gene encodes a member of a subfamily of LIM proteins, characterized by a LIM motif and a domain of Src homology region 3, and also a member of the nebulin family of actin-binding proteins. The encoded protein is a cAMP and cGMP dependent signaling protein and binds to the actin cytoskeleton at extensions of the cell membrane. The encoded protein has been linked to metastatic breast cancer, hematopoetic tumors such as B-cell lymphomas, and colorectal cancer. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 17-38918616-C-T is Benign according to our data. Variant chr17-38918616-C-T is described in ClinVar as [Benign]. Clinvar id is 778689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.19 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00568 (865/152308) while in subpopulation AFR AF= 0.0197 (819/41546). AF 95% confidence interval is 0.0186. There are 6 homozygotes in gnomad4. There are 409 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 865 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LASP1 | NM_006148.4 | c.624C>T | p.Arg208Arg | synonymous_variant | Exon 7 of 7 | ENST00000318008.11 | NP_006139.1 | |
LASP1 | NM_001271608.2 | c.456C>T | p.Arg152Arg | synonymous_variant | Exon 6 of 6 | NP_001258537.1 | ||
LASP1 | XM_047435965.1 | c.516C>T | p.Arg172Arg | synonymous_variant | Exon 7 of 7 | XP_047291921.1 | ||
LASP1 | NR_073384.2 | n.926C>T | non_coding_transcript_exon_variant | Exon 8 of 8 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00557 AC: 848AN: 152190Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
848
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00146 AC: 359AN: 245714Hom.: 2 AF XY: 0.000956 AC XY: 127AN XY: 132864
GnomAD3 exomes
AF:
AC:
359
AN:
245714
Hom.:
AF XY:
AC XY:
127
AN XY:
132864
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000619 AC: 895AN: 1446630Hom.: 3 Cov.: 31 AF XY: 0.000499 AC XY: 358AN XY: 716854
GnomAD4 exome
AF:
AC:
895
AN:
1446630
Hom.:
Cov.:
31
AF XY:
AC XY:
358
AN XY:
716854
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00568 AC: 865AN: 152308Hom.: 6 Cov.: 32 AF XY: 0.00549 AC XY: 409AN XY: 74486
GnomAD4 genome
AF:
AC:
865
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
409
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Mar 06, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at